Gemtesa 75 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FC68A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $55,683
Award facts
- Contract value 100% obligated
- $55,683.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $55,683.49 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (30-count units) on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant position within the federal medical supply chain, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As a child contract under the larger DLA Troop Support Medical IDC, this delivery order exemplifies the company's role as a critical vendor for federal pharmaceutical procurement, particularly for specialty medications and brand-name drugs supporting military and veteran healthcare operations. The rapid completion timeline reflects the urgent nature of pharmaceutical supply fulfillment within defense medical logistics.
Quick answers
Who was awarded contract SPE2DB25FC68A?
SPE2DB25FC68A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 6, 2025.
How much is contract SPE2DB25FC68A worth?
The government has obligated $55,683 on SPE2DB25FC68A.
Is contract SPE2DB25FC68A an order under another contract?
Yes. SPE2DB25FC68A is a delivery order under SPE2DB20D2014, an indefinite delivery contract.
Was contract SPE2DB25FC68A competed?
The extent of competition for SPE2DB25FC68A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award